http://www.cnr.it/ontology/cnr/individuo/prodotto/ID191341

Transaction costs and pharmaceutical clinical research: a Data Envelopment Analysis approach (Articolo in rivista)

Type

Label

Transaction costs and pharmaceutical clinical research: a Data Envelopment Analysis approach (Articolo in rivista) (literal)

Anno

Alternative label

Falavigna G, Ippoliti R. (2012)
Transaction costs and pharmaceutical clinical research: a Data Envelopment Analysis approach
in Working paper (CERIS-CNR, Online); CNR-CERIS, Moncalieri (Italia)
(literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#volumeInCollana

Rivista

Note

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni

CNR-Ceris, IEL International Program in Institutions, Economics and Law (literal)

Titolo

Transaction costs and pharmaceutical clinical research: a Data Envelopment Analysis approach (literal)

Abstract

Taking human experimentation into account, this work aims at estimating the relationship between transaction costs, which are related to the protection system of patients' rights, and localization of pharmaceutical industry's testing phase. Assuming that the competitiveness of the protection system is based on the time required to obtain an authorization or an experimental activity, pharmaceutical clinical research should be positively affected by a process aimed at internalizing the review process, if efficient. By analyzing said system with operational research, this paper concludes suggesting the potentiality of a competitive system of reviewers, that is to say, the efficiency of that internalization process is performed by medical centers in which the experimental treatments are proposed to subjects. (literal)

Editore